Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Kura Oncology, with a focus on how actual results compare to estimates impacting stock price [1] Earnings Expectations - Kura Oncology is expected to report a quarterly loss of $0.72 per share, reflecting a year-over-year change of -227.3% [3] - Revenues are projected to be $29.81 million, down 44.7% from the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised 552.38% lower in the last 30 days, indicating a significant reassessment by analysts [4] - The Most Accurate Estimate for Kura Oncology is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -13.29% [12] Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from consensus estimates, with predictive power being significant for positive readings only [9][10] - Kura Oncology currently holds a Zacks Rank of 4, complicating predictions of an earnings beat [12] Historical Performance - In the last reported quarter, Kura Oncology was expected to post a loss of $0.57 per share but actually reported a loss of -$0.85, resulting in a surprise of -49.12% [13] - Over the past four quarters, Kura has only beaten consensus EPS estimates once [14] Industry Context - In the Zacks Medical - Biomedical and Genetics industry, Apellis Pharmaceuticals is expected to report a loss of $0.39 per share, indicating a year-over-year change of -34.5% [18] - Apellis' revenue is projected to be $194.37 million, down 8.5% from the previous year, with an Earnings ESP of -3.07% [19][20]

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Imax, driven by higher revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - Imax is expected to report quarterly earnings of $0.43 per share, reflecting a year-over-year increase of +59.3% [3]. - Revenues are projected to reach $119.41 million, representing a 28.9% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 4.53% over the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Imax is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -15.72%, suggesting a bearish outlook from analysts [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict deviations from consensus estimates, but its predictive power is significant mainly for positive readings [9][10]. - Imax currently holds a Zacks Rank of 3, which complicates predictions of an earnings beat given the negative Earnings ESP [12]. Historical Performance - In the last reported quarter, Imax exceeded expectations by delivering earnings of $0.47 per share against an expected $0.38, resulting in a surprise of +23.68% [13]. - Over the past four quarters, Imax has beaten consensus EPS estimates three times [14]. Conclusion - While Imax does not appear to be a strong candidate for an earnings beat, investors should consider other factors influencing stock performance ahead of the earnings release [17].

Core Viewpoint - Sarepta Therapeutics (SRPT) is anticipated to report a year-over-year decline in earnings due to lower revenues, with a consensus outlook indicating a quarterly loss of $0.71 per share, reflecting a -147.3% change from the previous year, and revenues expected to be $408.53 million, down 38% from the year-ago quarter [1][3]. Earnings Expectations - The upcoming earnings report is scheduled for February 25, and the stock may rise if the reported numbers exceed expectations, while a miss could lead to a decline [2]. - The consensus EPS estimate has been revised down by 45.87% over the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP (Expected Surprise Prediction) model suggests that the Most Accurate Estimate for Sarepta is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +2.11% [12]. - The stock currently holds a Zacks Rank of 3, indicating a hold position, which suggests a likelihood of beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Sarepta was expected to post earnings of $0.01 per share but instead reported a loss of -$0.13, resulting in a surprise of -1,400.00% [13]. - Over the past four quarters, the company has only beaten consensus EPS estimates once [14]. Industry Context - In the broader context of the Zacks Medical - Biomedical and Genetics industry, Cytokinetics (CYTK) is also expected to report a loss of $1.48 per share, reflecting a year-over-year change of -17.5%, with revenues expected to be $3.89 million, down 77% from the previous year [18][19].

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Sterling Infrastructure, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - Sterling Infrastructure is expected to report quarterly earnings of $2.66 per share, reflecting an increase of +82.2% year-over-year [3]. - Revenues are projected to reach $647.81 million, marking a growth of 29.9% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised 3.89% higher in the last 30 days, indicating a positive reassessment by analysts [4]. - The Most Accurate Estimate for Sterling Infrastructure is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +2.01% [11]. Earnings Surprise Prediction - A positive Earnings ESP is a strong indicator of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [9]. - Sterling Infrastructure holds a Zacks Rank of 3, suggesting a likelihood of beating the consensus EPS estimate [11]. Historical Performance - In the last reported quarter, Sterling Infrastructure exceeded expectations by delivering earnings of $3.48 per share against an expected $2.79, resulting in a surprise of +24.73% [12]. - The company has consistently beaten consensus EPS estimates over the last four quarters [13]. Industry Context - In the Zacks Engineering - R and D Services industry, VSE is expected to report earnings of $0.88 per share, indicating a year-over-year decline of -2.2% [17]. - VSE's revenue is projected to be $294.6 million, down 1.5% from the previous year [17].

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Marriott Vacations Worldwide due to lower revenues, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - The upcoming earnings report is expected on February 25, with a consensus estimate of $1.72 per share, reflecting a year-over-year decrease of 7.5% [3]. - Revenues are projected to be $1.32 billion, down 0.2% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised 1.94% higher in the last 30 days, indicating a reassessment by analysts [4]. - However, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -4.67%, suggesting a bearish outlook from analysts [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict deviations from consensus estimates, but its predictive power is significant mainly for positive readings [9][10]. - The current Zacks Rank for Marriott Vacations Worldwide is 3, making it challenging to predict an earnings beat conclusively [12]. Historical Performance - In the last reported quarter, the company exceeded expectations with earnings of $1.69 per share against an estimate of $1.64, resulting in a surprise of +3.05% [13]. - Over the past four quarters, Marriott Vacations Worldwide has beaten consensus EPS estimates each time [14]. Industry Context - In the broader leisure and recreation services industry, Pursuit Attractions and Hospitality is expected to report a loss of $0.81 per share, with revenues projected to increase by 27.2% year-over-year [19]. - Pursuit Attractions and Hospitality has a negative Zacks Rank of 4, complicating predictions for an earnings beat despite a positive Earnings ESP of +4.94% [20].

Core Viewpoint - Acadia Pharmaceuticals (ACAD) is anticipated to report a year-over-year decline in earnings despite an increase in revenues for the quarter ending December 2025, with the consensus outlook indicating a significant impact on its stock price based on actual results compared to estimates [1][2]. Earnings Expectations - The upcoming earnings report is expected to show earnings of $0.12 per share, reflecting a year-over-year decrease of 29.4%, while revenues are projected to be $292.58 million, representing a 12.7% increase from the previous year [3]. - The consensus EPS estimate has been revised 3.23% higher in the last 30 days, indicating a reassessment by analysts regarding the company's earnings prospects [4]. Earnings Surprise Prediction - The Zacks Earnings ESP (Expected Surprise Prediction) model suggests that a positive Earnings ESP reading of +14.92% indicates a likelihood of Acadia beating the consensus EPS estimate, although the company currently holds a Zacks Rank of 3 [12]. - Historical performance shows that Acadia has beaten consensus EPS estimates three out of the last four quarters, with a notable surprise of +85.71% in the last reported quarter [13][14]. Industry Context - Day One Biopharmaceuticals, another player in the same industry, is expected to report a loss of $0.17 per share for the same quarter, which is a year-over-year increase of 75.4%, with revenues expected to rise by 65.1% to $48.22 million [18][19]. - Despite a significant upward revision of 53.1% in the consensus EPS estimate for Day One Biopharmaceuticals over the last 30 days, it currently has a negative Earnings ESP of -29.00%, complicating predictions for beating the consensus EPS estimate [19][20].

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for C3.ai, Inc. due to lower revenues, with a focus on how actual results will compare to estimates [1][2]. Earnings Expectations - C3.ai is expected to report a quarterly loss of $0.29 per share, reflecting a year-over-year change of -141.7% [3]. - Revenues are projected to be $75.82 million, down 23.2% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating a stable outlook from covering analysts [4]. - The Most Accurate Estimate for C3.ai is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -9.40% [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from the consensus estimate, with significant predictive power for positive readings only [9][10]. - C3.ai currently holds a Zacks Rank of 4, making it challenging to predict an earnings beat [12]. Historical Performance - In the last reported quarter, C3.ai was expected to post a loss of $0.32 per share but delivered a loss of -$0.25, resulting in a surprise of +21.88% [13]. - The company has beaten consensus EPS estimates in the last four quarters [14]. Industry Comparison - CoStar Group, another player in the IT Services industry, is expected to report earnings per share of $0.27, indicating a year-over-year change of +3.9% [18]. - CoStar's revenues are projected to be $891.08 million, up 25.6% from the previous year [18].

Core Viewpoint - The market anticipates a year-over-year decline in earnings for Permian Resources due to lower revenues, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Permian Resources is expected to report quarterly earnings of $0.28 per share, reflecting a year-over-year decrease of 22.2% [3]. - Revenues are projected to be $1.29 billion, a slight decline of 0.3% compared to the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 17.42% over the last 30 days, indicating a bearish sentiment among analysts regarding the company's earnings prospects [4]. - The Most Accurate Estimate for Permian Resources is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -1.35% [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from the consensus estimate, with positive readings being more predictive of earnings beats [9][10]. - Permian Resources currently holds a Zacks Rank of 3, making it challenging to predict an earnings beat [12]. Historical Performance - In the last reported quarter, Permian Resources exceeded the consensus EPS estimate of $0.30 by delivering earnings of $0.37, resulting in a surprise of +23.33% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates two times [14]. Industry Comparison - Gulfport Energy, a peer in the oil and gas exploration and production sector, is expected to report earnings of $5.77 per share, indicating a year-over-year increase of 20.2% [18]. - Gulfport's revenues are anticipated to reach $373.24 million, up 55.6% from the previous year, with an Earnings ESP of +3.02% suggesting a likely earnings beat [19][20].

Core Viewpoint - Bank of Montreal (BMO) is anticipated to report a year-over-year increase in earnings driven by higher revenues for the quarter ending January 2026, with a consensus outlook suggesting a positive earnings picture [1] Earnings Expectations - The upcoming earnings report is expected to reveal quarterly earnings of $2.39 per share, reflecting an 11.7% increase year-over-year, and revenues are projected to be $6.63 billion, up 1.7% from the previous year [3] - The stock price may rise if these key figures exceed expectations, while a miss could lead to a decline [2] Estimate Revisions - The consensus EPS estimate has been revised 6.98% higher in the last 30 days, indicating a reassessment by analysts [4] - The Most Accurate Estimate aligns with the Zacks Consensus Estimate, resulting in an Earnings ESP of 0%, suggesting no recent differing views from analysts [12] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict deviations from consensus estimates, with positive readings being more reliable [9][10] - The stock currently holds a Zacks Rank of 2, which complicates predictions of an earnings beat [12] Historical Performance - In the last reported quarter, BMO exceeded the expected earnings of $2.16 per share by delivering $2.36, resulting in a surprise of +9.26% [13] - Over the past four quarters, the company has beaten consensus EPS estimates three times [14] Conclusion - While BMO does not appear to be a strong candidate for an earnings beat, investors should consider other factors when making decisions regarding the stock ahead of the earnings release [17]

Core Viewpoint - APA is expected to report a year-over-year decline in earnings and revenues for the quarter ended December 2025, which could significantly impact its stock price depending on how actual results compare to estimates [1][3]. Earnings Expectations - The consensus estimate for APA's quarterly earnings is $0.62 per share, reflecting a year-over-year decrease of 21.5% [3]. - Revenues are projected to be $1.92 billion, down 23.2% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 5.13% lower in the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for APA is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +0.28% [12]. Earnings Surprise Prediction - A positive Earnings ESP reading suggests a potential earnings beat, especially when combined with a strong Zacks Rank [10]. - However, APA currently holds a Zacks Rank of 4, which complicates the prediction of an earnings beat despite the positive Earnings ESP [12]. Historical Performance - In the last reported quarter, APA exceeded the consensus EPS estimate of $0.74 by delivering earnings of $0.93, resulting in a surprise of +25.68% [13]. - Over the past four quarters, APA has beaten consensus EPS estimates three times [14]. Industry Comparison - Matador Resources, another company in the oil and gas sector, is expected to report earnings of $0.79 per share for the same quarter, indicating a year-over-year decline of 56.8% [18]. - Matador's revenues are expected to be $830.78 million, down 14.4% from the previous year, with a Zacks Rank of 4 and an Earnings ESP of -5.58% [19][20].